Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

NCT00004878 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped study never opened

Conditions

Graft Versus Host Disease
Leukemia

Interventions

BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cytarabine
DRUG: fludarabine phosphate
DRUG: idarubicin
DRUG: methotrexate
DRUG: tacrolimus
PROCEDURE: in vitro-treated peripheral blood stem cell transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Jonsson Comprehensive Cancer Center